Tag Archives: NLSN

top 50 stocks to invest in

Investors looking to take advantage of rising oil prices have turned to crude oil stocks in 2017. But, even though oil prices have risen 16% since the OPEC deal on Nov. 30, not every oil stock is worth owning.

That’s why we’ve listed the top oil stocks to avoid in 2017…

Investors are right to target oil stocks as crude oil prices rise. The NYSE Arca Oil Index (NYSE Arca: XOI) is an index tracking the performance of oil companies across the industry. XOI is up 9.3% since Nov. 30.

But just because oil stocks have risen doesn’t mean they are all good investments.

We’ll show you some of the best oil stocks to buy, including one with 47% gains in 2016. Before we get to that, these are the crude oil stocks investors should avoid in 2017…

Crude Oil Stocks That Aren’t Worth Owning

Savvy oil investors will avoid buying stock in Big Oil in 2017.

Oil “supermajors,” or Big Oil, are massive oil companies largely consolidated in the 1990s. These oil companies handle everything from exploration, production, refining, transportation, and even gas stations.

top 50 stocks to invest in: MGC Diagnostics Corporation(MGCD)

Advisors’ Opinion:

  • [By Lisa Levin]

    MGC Diagnostics Corp (NASDAQ: MGCD) shares shot up 24 percent to $10.94 after the company agreed to be acquired by Altus Capital Partners for $11.03 per share in cash.

  • [By Monica Gerson]

    MGC Diagnostics Corp (NASDAQ: MGCD) is projected to post earnings for the latest quarter.

    Lands’ End, Inc. (NASDAQ: LE) is estimated to report its quarterly earnings at $0.02 per share on revenue of $293.24 million.

  • [By Lisa Levin]

    MGC Diagnostics Corp (NASDAQ: MGCD) shares shot up 24 percent to $10.92 after the company agreed to be acquired by Altus Capital Partners for $11.03 per share in cash.

top 50 stocks to invest in: VIVUS, Inc.(VVUS)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.

top 50 stocks to invest in: Alaska Air Group, Inc.(ALK)

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    It’s been clear from the beginning that Alaska Air’s (NYSE:ALK) acquisition of Virgin America was bad news for United Continental (NYSE:UAL). Alaska Air’s management viewed the deal as a springboard for growth in California — especially in the Bay Area. Meanwhile, United is the dominant airline in San Francisco.

  • [By Paul Ausick]

    The best airline, overall, was Alaska Air Group Inc. (NYSE: ALK). Other category winners were Spirit Airlines Co. (NASDAQ: SAVE), which was ranked cheapest; Alaska rated most reliable; JetBlue Airways Inc. (NASDAQ: JBLU) was most comfortable; best for pets was Alaska; and the airline receiving the fewest complaints was Southwest Airlines Co. (NYSE: LUV).

  • [By Adam Levine-Weinberg]

    While Southwest Airlines achieved the best score overall, Alaska Air (NYSE:ALK) received top marks among traditional carriers. This was its 10th consecutive victory in the traditional carrier segment.

top 50 stocks to invest in: Nielsen N.V.(NLSN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Nielsen Holdings plc (NYSE: NLSN) dropped about 1.5% Thursday to post a new 52-week low of $40.97 after closing Wednesday at $41.59. The 52-week high is $55.94. Volume of around 5.2 million was about 70% above the daily average of around 3.2 million shares traded. The company had no specific news Thursday.

  • [By Paul Ausick]

    Nielsen Holdings plc (NYSE: NLSN) lost nearly 2.7% Friday to post a new 52-week low of $42.25 after closing Thursday at $43.41. The 52-week high is $55.94. Volume of around 6.7 million was nearly 3 times the daily average of around 2.6 million shares traded. The data research and information company had no specific news Friday.

Top 10 Performing Stocks To Watch For 2018

As the end of the year nears, companies will start to report their end of the year numbers giving investors the opportunity to find value for their portfolios in 2017. Earlier this week, Nordson Corporation (NASDAQ:NDSN) released its numbers for the fourth quarter of its 2016 fiscal year. The machinery company, with market capitalization of just under $6.00 billion, specializes in a variety of manufacturing technologies across its segments, Adhesive Dispensing Systems, Advanced Technology Systems, and Industrial Coating Systems. After its fourth quarter earnings report, NDSN may have proven that it has the right value for a long-term play in an overbought market.

According to prices on December 14th, NDSN is up almost 80 percent year to date compared to the S&P 500 ETF’s (NYSEARCA:SPY) gain of about 14 percent. The stock has made a bullish run off of three solid earnings reports earlier in 2016, each boosting share prices by about 10 percent. As a mid-cap stock, it’s proven to be a more worthy growth stock as well, outperforming the S&P Mid-cap 400 which has grown by just over 20 percent this year. Currently, the stock is trading at all-time highs caused by bullish momentum from the so called “Trump Rally.” Another rally spurred by the recent earnings numbers could push NDSN even higher as investors opt for a position in the machinery company. How solid is this company? And do the fundamentals justify the technical strength the stock is showing?

Top 10 Performing Stocks To Watch For 2018: Siebert Financial Corp.(SIEB)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggested shorting small cap discount brokerageSiebert Financial Corp (NASDAQ: SIEB):

    Siebert Financial has been on our watchlist for a while, overbought and toying with the idea of a pullback. We’re finally starting to see evidence that the weight of the gain is taking a toll. We’ve seen a string of lower highs following the last bullish gasp from the 9th. We’re going to assume that was the pivot point. (It has been so far, anyway.)

  • [By Garrett Baldwin]

    William may be right about a sell-off in stocks… in the cryptocurrency space. Over the last week, companies that have billed themselves as blockchain-focused saw their stocks surge. One firm – Long Island Iced Tea changed its name to Long Island Blockchain and watched its stock surge more than triple digits. But today, firms with this exposure are cratering. MGT Capital Investments Inc. (OTCMKTS: MGTI), Long Island Iced Tea Corp. (Nasdaq: LTEA), Riot Blockchain Inc. (Nasdaq: RIOT), and Siebert Financial Corp. (Nasdaq: SIEB) all fell by more than 12% Friday.

  • [By Lisa Levin]

    Siebert Financial Corp. (NASDAQ: SIEB) shares shot up 61 percent to $8.30 following news it will offer deeply discounted online trading of U.S. equities next year.

  • [By Cameron Saucier]

    Siebert (Nasdaq: SIEB) is a holding company that has a retail discount brokerage business through its subsidiary, Muriel Siebert & Co. SIEB rose 60% last month after it announced a purchasing agreement with Kennedy Cabot Acquisition. Under the agreement, Kennedy Cabot will purchase shares of SIEB. SIEB is currently trading at $3.37 per share and is up 157% YOY.

Top 10 Performing Stocks To Watch For 2018: Nestl茅 S.A. (NSRGF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    In sum, the three companies are equally valued at generous multiples. It is difficult to choose one of them based on fundamentals or valuations, but we like the strategy of Nestl茅 and P&G more than Unilever. Therefore, we recommend investing in these companies only if someone is interested in a limited but relatively safe upside potential. Good entry prices would be as follows: Nestl茅 (OTCPK:NSRGF) at CHF 70.1 or $70.1 for the ADR , P&G at $83.6 and Unilever (OTC:UNLVF) at 34.1 or $38 for the ADR (NYSE:UN).

  • [By SEEKINGALPHA.COM]

    A recently updated map from HowMuch.net ranking the world’s most valuable brands by country in 2017 shows that Apple Inc. (AAPL) lost its spot as the US’s most valuable brand. Of these, the top 10 most valuable brands with shares or ADRs traded in the US are:

    US-based search engine and Google parent Alphabet Inc (GOOG) (NASDAQ:GOOGL) Swiss food giant Nestle (OTCPK:NSRGF) Korea’s Samsung Electronics (OTC:SSNLF) – part of a larger group of Samsung brands China’s (and the world’s) largest bank ICBC (OTCPK:IDCBF) Japanese automaker Toyota (TM) Irish medical equipment maker Medtronic (MDT) Royal Dutch Shell, the oil company (RDS.A) Royal Bank of Canada (RY) Spanish bank Santander (SAN), and Hong Kong-based insurer AIA (OTCPK:AAGIY)

    In 11th and 12 place, by market cap, are British telecom Vodafone Plc (VOD) and German automaker BMW (OTCPK:BMWYY), whose brands are valued at 2-4x AIA’s according the map, but whose market caps trade at significantly lower multiples in the current market environment.

Top 10 Performing Stocks To Watch For 2018: Sohu.com Inc.(SOHU)

Advisors’ Opinion:

  • [By Lisa Levin]

    Sohu.com Inc (NASDAQ: SOHU) shares were also up, gaining 14 percent to $57.89. Sohu.com reported a Q2 loss of $1.85 per share on revenue of $461.168 million.

  • [By R. Chandrasekaran]

    The following stocks are rated Underweight:

    Baidu. Sohu.com Inc (NASDAQ: SOHU).

    Full ratings data available on Benzinga Pro.

    Do you have ideas for articles/interviews you’d like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!

  • [By Belinda Cao]

    Sohu.com Inc. (SOHU), which sold a stake in its search unit to Tencent Holdings Ltd. (700), advanced 11 percent for the week to $72.06. It retreated 5.9 percent Sept. 20. Tencent, Chinas biggest Internet company by market value, paid $448 million for a 36.5 percent stake in Sohus Sogou unit last week and merge its own search service with Sogou.

  • [By Matthew Smith]

    Shares in Sohu.com (SOHU) continued their rapid rise, hitting yet another fresh 52-week high during the session, as the company announced the special dividend from Sohou yesterday (press release located here). Sohu.com will receive nearly $161.2 million in the transaction which is part of the overall $400 million deal with Tencent (TCEHY.PK) which was announced not too long ago. These are exciting times in the internet space as we move from computers to mobile devices, but China’s internet landscape looks like the ‘Wild West’ right now and we expect to see further deals as companies jockey for position in their respective niches and consolidation begins as the larger players look to step up growth and gain exposure to new business segments.

  • [By Wayne Duggan]

    Sogou is Baidu’s biggest rival when it comes to mobile search engine market share. The app is owned by Sohu.com Inc (NASDAQ: SOHU), and its position as second fiddle to Baidu makes it most similar to Microsoft Corporation (NASDAQ: MSFT)’s Bing.

  • [By Roberto Pedone]

    Sohu.com (SOHU) is a Chinese online media, search, gaming, community and mobile service group. This stock closed up 7.5% to $69.61 in Monday’s trading session.

    Monday’s Volume: 4.90 million

    Three-Month Average Volume: 1.01 million

    Volume % Change: 351%

    From a technical perspective, SOHU ripped sharply higher here with heavy upside volume. This move pushed shares of SOHU into breakout territory, since the stock took out some near-term overhead resistance at $67.80. Shares of SOHU are now quickly moving within range of triggering another breakout trade. That trade will hit if SOHU manages to take out Monday’s high of $69.71 to its 52-week high at $70.63 with high volume.

    Traders should now look for long-biased trades in SOHU as long as it’s trending above Monday’s low of $66.95 or above that first breakout level of $67.80 and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.01 million shares. If that breakout hits soon, then SOHU will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $75 to $80.

Top 10 Performing Stocks To Watch For 2018: FLIR Systems, Inc.(FLIR)

Advisors’ Opinion:

  • [By Peter Graham]

    Oregon based small cap FLIR Systems (NASDAQ: FLIR) was founded in 1978 as a world-leading maker of sensor systems that enhance perception and heighten awareness, helping to save lives, improve productivity, and protect the environment. Through its nearly 3,500 employees, the Company’s vision is to be “The World’s Sixth Sense” by leveraging thermal imaging and adjacent technologies to provide innovative, intelligent solutions for security and surveillance, environmental and condition monitoring, outdoor recreation, machine vision, navigation, and advanced threat detection.

  • [By Jim Robertson]

    Small cap homeland security and screening stocks like FLIR Systems (NASDAQ: FLIR), OSI Systems (NASDAQ: OSIS),Varex Imaging Corp (NASDAQ: VREX) and Patriot One Technologies (OTCQB: PTOTF) stand to benefit fromTrumps focus on border andinternal security in general. Heres what you need to know about all four:

  • [By Peter Graham]

    Oregon based small cap FLIR Systems (NASDAQ: FLIR) was founded in 1978 as a world-leading maker of sensor systems that enhance perception and heighten awareness, helping to save lives, improve productivity, and protect the environment. Through its nearly 3,500 employees, the Company’s vision is to be “The World’s Sixth Sense” by leveraging thermal imaging and adjacent technologies to provide innovative, intelligent solutions for security and surveillance, environmental and condition monitoring, outdoor recreation, machine vision, navigation, and advanced threat detection.

  • [By Teresa Rivas]

    Flir Systems(FLIR) was the biggest loser in the S&P 500 on Tuesday, but the stock recouped all its losses Wednesday, and then some.

    Getty Images

    Flir Systems gained $2.78, or 8.1%, to close at $36.93.

    The company’sdisappointing fourth-quarter earnings report was forgotten when it announced that the U.S. Coast Guard awarded it a $50 million contract. Flir will provide marine electronics systems for more than 2,000 Coast Guard vessels for its Scalable Integrated Navigation Systems 2 (SINS-2) program over a five-year period, with the option for extended delivery for an additional five years.

    Even before the news, Imperial Capital’sEd Mally was bullish on the stock’s prospects, who raised his price target on the stock by $2, to $38:

    Although we believe that some may still consider Flir as just a premier provider of very high-end cameras in the bellies of Bell Helicopters or border towers in a lumpy government sector, this 35-year-old company is a global leader in thousands of infrared detector cores and thermography equipment markets and also provides lower priced products to commercial and consumer security customers as well as other customers.

    Flir is up 2% so far this year.

    Coty(COTY) was the hottest stock in the S&P 500 yesterday.

Top 10 Performing Stocks To Watch For 2018: GlaxoSmithKline PLC(GSK)

Advisors’ Opinion:

  • [By Keith Speights]

    There are several choices for investing in HIV drug stocks. Three of the best options for long-term investors are Gilead Sciences (NASDAQ:GILD), GlaxoSmithKline (NYSE:GSK), and Merck (NYSE:MRK). Here’s why these HIV drug stocks could be solid picks in 2017.

  • [By Sean Williams]

    Third, in late March, Mylan announced that the Food and Drug Administration had rejected its application to market a generic version of GlaxoSmithKline’s (NYSE:GSK) blockbuster asthma and COPD inhalable drug, Advair. GlaxoSmithKline’s Advair lost patent protection more than six years ago, but only within the past couple of years did the FDA lay out a course for generic drug producers to follow in order to get a generic version of the drug approved. Meanwhile, Glaxo still enjoys blockbuster sales of Advair as generic versions of the drug have yet to hit the market.

  • [By WWW.MONEYSHOW.COM]

    Two of our top holdings, GlaxoSmithKline (GSK) and Merck (MRK) have seen substantial improvement in earnings as new drugs start to build market share. Glaxo and Merck offer dividend yields of 4.71% and 3.08%, respectively.

  • [By Paul Ausick]

    GlaxoSmithKline plc (NYSE: GSK) dropped about 1% Wednesday to post a new 52-week low of $34.52 after closing at $34.86 on Tuesday. The stock’s 52-week high is $44.54. Volume of around 4.8 million was about equal to the daily average. The company’s HIV drug is being challenged by a potentially better drug from competitor Gilead Sciences.

Top 10 Performing Stocks To Watch For 2018: Radiant Logistics, Inc.(RLGT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Wednesday afternoon, the cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Lithia Motors Inc (NYSE: LAD) and Radiant Logistics Inc (NYSE: RLGT).

  • [By Monica Gerson]

    Some of the stocks that may grab investor focus today are:

    United Natural Foods, Inc. (NASDAQ: UNFI) reported better-than-expected earnings for its fourth quarter on Monday. United Natural Foods shares gained 1.51 percent to $42.45 in the after-hours trading session.
    Wall Street expects Radiant Logistics Inc (NYSE: RLGT) to post quarterly earnings at $0.03 per share on revenue of $202.06 million after the closing bell. Radiant Logistics shares rose 3.68 percent to close at $3.10 on Monday.
    Anadarko Petroleum Corporation (NYSE: APC) announced the acquisition of Freeport-McMoRan Inc (NYSE: FCX)’s deepwater Gulf of Mexico assets for $2 billion. The company also reported an offering of 35.25 million shares of common stock. Anadarko Petroleum shares dropped 2.92 percent to $56.10 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top 10 Performing Stocks To Watch For 2018: Nielsen N.V.(NLSN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Nielsen Holdings plc (NYSE: NLSN) lost nearly 2.7% Friday to post a new 52-week low of $42.25 after closing Thursday at $43.41. The 52-week high is $55.94. Volume of around 6.7 million was nearly 3 times the daily average of around 2.6 million shares traded. The data research and information company had no specific news Friday.

  • [By Paul Ausick]

    Nielsen Holdings plc (NYSE: NLSN) dropped about 1.5% Thursday to post a new 52-week low of $40.97 after closing Wednesday at $41.59. The 52-week high is $55.94. Volume of around 5.2 million was about 70% above the daily average of around 3.2 million shares traded. The company had no specific news Thursday.

Top 10 Performing Stocks To Watch For 2018: Duluth Holdings Inc.(DLTH)

Advisors’ Opinion:

  • [By Jason Hall, Travis Hoium, and Brian Feroldi]

    In our ongoing search for just such quality growth stocks, we asked three of our contributors to pick out ones they think have high growth potential from here, and tell us why. They gave us a unique retailer that’s carving out a huge following in Duluth Holdings(NASDAQ:DLTH), a recovering fast-casual dining darling inChipotle Mexican Grill (NYSE:CMG), and a gaming and resorts giant,Wynn Resorts (NASDAQ:WYNN).

  • [By Monica Gerson]

    Duluth Holdings Inc (NASDAQ: DLTH) is projected to post its quarterly earnings at $0.28 per share on revenue of $133.21 million.

    DBV Technologies SA ADR (NASDAQ: DBVT) is expected to post a quarterly loss at $0.60 per share.

  • [By Lisa Levin]

    Duluth Holdings Inc (NASDAQ: DLTH) shares were also up, gaining 23 percent to $21.94 as the company reported upbeat results for its fourth quarter on Thursday.

  • [By Monica Gerson] Related DLTH After-Hours Recap: CarMax, Wynn, Relypsa, ConAgra, Ruby Tuesday & More Earnings Scheduled For April 7, 2016 Duluth Holdings' (DLTH) CEO Stephanie Pugliese on Q4 2015 Results – Earnings Call Transcript (Seeking Alpha)
    Related GPS After-Hours Recap: CarMax, Wynn, Relypsa, ConAgra, Ruby Tuesday & More Gap Comps Down 6% In March; Shares Plunge Difficult March Comparisons Were Too High For Retailers To Beat (Seeking Alpha)

    Some of the stocks that may grab investor focus today are:

Top 10 Performing Stocks To Watch For 2018: Aimmune Therapeutics, Inc.(AIMT)

Advisors’ Opinion:

  • [By Jim Robertson]

    Small cap clinical-stage biopharmaceutical stock Aimmune Therapeutics (NASDAQ: AIMT) is aclinical-stage biopharmaceutical company developing treatments for life-threatening food allergies. The Companys Characterized Oral Desensitization ImmunoTherapy (CODIT) approach is intended to achieve meaningful levels of protection by desensitizing patients with defined, precise amounts of key allergens. Aimmune Therapeutics first investigational biologic product using CODIT⒙is AR101 for the treatment of peanut allergy.AR101 has received the FDAs Breakthrough Therapy Designation for the desensitization of peanut-allergic patients 4-17 years of age and is currently being evaluated in Phase 3 clinical trials where enrollment was announced last month.

  • [By Lisa Levin] Gainers
    Aimmune Therapeutics Inc (NASDAQ: AIMT) shares jumped 35 percent to $34.64 in response to failed DBVT peanut allergy trial.
    Exactech, Inc. (NASDAQ: EXAC) shares surged 30.9 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.
    Dextera Surgical Inc (NASDAQ: DXTR) shares climbed 27.6 percent to $0.238 after surging 40.48 percent on Friday.
    Petmed Express Inc (NASDAQ: PETS) jumped 21.8 percent to $44.73 as the company reported better-than-expected Q2 results.
    SenesTech Inc (NASDAQ: SNES) shares surged 21.7 percent to $1.95 after the company disclosed that Univar will be marketing and selling ContraPest.
    Yulong Eco-Materials Ltd (NASDAQ: YECO) shares gained 18.3 percent to $0.560.
    One Horizon Group Inc (NASDAQ: OHGI) shares rose 18 percent to $1.18.
    Atossa Genetics Inc (NASDAQ: ATOS) shares climbed 18 percent to $0.566. Atossa Genetics is schedule to host a conference call to announce preliminary results from Phase 1 study of oral Endoxifen on October 25, 2017.
    ReneSola Ltd. (ADR) (NYSE: SOL) shares rose 15.3 percent to $2.72
    Renren Inc (NYSE: RENN) shares gained 11.9 percent to $10.71 after gaining 2.68 percent on Friday.
    Kalvista Pharmaceuticals Inc (NASDAQ: KALV) shares rose 11.8 percent to $12.59. KalVista Pharma 13D filing from Longwood Fund showed registration for an 8.7 percent stake.
    Xunlei Ltd (NASDAQ: XNET) shares gained 9.4 percent to $7.20 after surging 25.33 percent on Friday.
    VF Corp (NYSE: VFC) shares surged 7.1 percent to $71.09 after the company reported upbeat earnings for its third quarter and raised its FY2017 guidance.
    CAI International Inc (NYSE: CAI) rose 6.6 percent to $39.70. Cowen & Co. upgraded CAI from Market Perform to Outperform.
    Agenus Inc (NASDAQ: AGEN) shares gained 5.7 percent to $4.58 as the company disclosed that GSK's shingle vaccine received FDA approval.
    Deltic Timber Corp (NYSE: DEL) shares climbed 5.6 percent to $94.11
  • [By Lisa Levin]

    Shares of Aimmune Therapeutics Inc (NASDAQ: AIMT) got a boost, shooting up 35 percent to $34.73 in response to failed DBVT peanut allergy trial.

    Exactech, Inc. (NASDAQ: EXAC) shares were also up, gaining 31 percent to $41.88 after the company agreed to be acquired by TPG Capital for $42 per share in cash.

Top 10 Performing Stocks To Watch For 2018: Federal Agricultural Mortgage Corporation(AGM)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Agri-Finance Companies

    Federal Agricultural Mortgage Corp. (NYSE: AGM): +233 percent since 2011.

    Notwithstanding the drought, seed companies and agri-produce companies have fared well. The performance of pesticide and fertilizer companies were mixed during the period.

good stocks

Timeline: The rise and fall of Yahoo Marissa Mayer will step down from Yahoo’s board of directors if its sale to Verizon goes through, according to a company filing on Monday.

The Yahoo CEO’s pending resignation from the board is part of a broader restructuring. After completing the $4.8 billion sale of its core Internet assets to Verizon (VZ, Tech30), what remains of Yahoo (YHOO, Tech30) will effectively be converted into an investment company for its Alibaba (BABA, Tech30) holdings.

Fittingly, that company will be renamed Altaba, according to the filing with the Securities and Exchange Commission.

Yahoo, wait sorry, we mean Altaba (this takes some getting used to), will then shrink its board to five directors. Yahoo cofounder David Filo and chairman Maynard Webb also intend to step down from the board.

good stocks: Arena Pharmaceuticals, Inc.(ARNA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) were down around 18 percent to $1.22. Arena Pharmaceuticals priced its 60 million share offering at $1.15 per share.

  • [By Keith Speights]

    Eisai partnered with Arena Pharmaceuticals (NASDAQ:ARNA) several years ago on obesity drug Belviq. The drug won U.S. regulatory approval in 2012, but sales have been underwhelming. As a result, Arena sold Belviq to Eisai earlier this year.

  • [By Paul Ausick]

    Arena Pharmaceuticals Inc. (NASDAQ: ARNA) posted a new 52-week low of $1.20 on Tuesday, down about 19% compared with Monday’s closing price of $1.48. The stock’s 52-week high is $2.16. Volume was about 10% below the daily average of around 3.8 million shares. The company priced a secondary offering of 60 million shares at $1.15 per share, a path guaranteed to enrage existing investors.

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 0.09 percent. Meanwhile, top losers in the sector included Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), down 6 percent, and Omeros Corporation (NASDAQ: OMER), down 5 percent.

  • [By Peter Graham]

    The Q4 2016 earnings report for small cap obesity drug stock Arena Pharmaceuticals, Inc (NASDAQ: ARNA) is scheduled for after the market closes onTuesday (March 14th). Last June,Arena Pharmaceuticals announced a strategic shifting of priorities to emphasize its proprietary clinical stage pipeline and the implementation of additional cost reductions to streamline the organization to support its development programs. Among the actions to be taken is the layoff of 73% of the companys workforce which will cost approximately $6.1 million.

good stocks: Brady Corporation(BRC)

Advisors’ Opinion:

  • [By Mike Deane]

    For the 28th year in a row, Brady Corp (BRC) has increased its dividend payout to investors.

    The Milwaukee, WI-based company increased its quarterly dividend to 19.5 cents from 19 cents, an increase of 2.6%. The annual dividend now stands at 78 cents. The quarterly dividend will be paid on October 31st, 2013 to all shareholders of record on October 10, 2013.

    BRC shares were down 40 cents, or 1.23%, by market close on Wednesday. YTD, the company’s stock is down over 4%.

  • [By Shauna O’Brien]

    Robert Baird announced on Friday that it has cut its rating on Brady Corp (BRC).

    The firm has downgraded BRC from “Outperform” to “Neutral,” and has given the company a $33 price target. This price target suggests a 8% upside from the stock’s current price of $30.52.

    Analysts see the company’s WPS segment growing faster than expected.

    Brady shares were mostly flat during pre-market trading Friday. The stock is down 9% YTD.

  • [By Michael Flannelly]

    Before the opening bell on Thursday, identification solutions provider Brady Corp (BRC) posted a loss in the fourth quarter, despite a rise in revenues, as it was negatively impacted by a number of charges. However, excluding these charges, the company was able to top Wall Street analysts’ earnings and sales estimates. Nonetheless, BRC shares are plummeting in Thursday’s trading.

    The Milwaukee, Wisconsin-based company posted a loss from continuing operations of $176.2 million, or $3.41 per share, in the fourth quarter, versus last year’s fourth quarter earnings from continuing operations of $20.9 million, or 40 cents per share. Furthermore, Brady posted a net loss of $177.2 million, or $3.43 per share, compared to net earnings of $11.6 million, or 22 cents per share, in the same period a year ago.

    The fourth quarter loss includes non-cash impairment charges of $204.4 million, $15.6 million in restructuring charges, and $4 million in acquisition-related charges. Excluding these charges, Brady Corp said earnings would have been 53 cents per share in the quarter. According to analysts polled by Thomson Reuters, the company was expected to earn an adjusted 51 cents per share in the fourth quarter.

    The company’s fourth quarter sales came in at $309.1 million, up 15% from $269.1 million in sales posted last year. On average, analysts were expecting the company to see $307.13 million in revenues for the quarter.

    Looking ahead, Brady Corp. sees fiscal 2014 earnings coming in between $1.80 and $2.00 per share, below the analysts’ view of $2.30 per share.

    Brady Corp shares were down $1.71, or 5.25%, during early morning trading on Thursday. The stock is up 7.93% year-to-date.

good stocks: Nielsen N.V.(NLSN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Nielsen Holdings plc (NYSE: NLSN) lost nearly 2.7% Friday to post a new 52-week low of $42.25 after closing Thursday at $43.41. The 52-week high is $55.94. Volume of around 6.7 million was nearly 3 times the daily average of around 2.6 million shares traded. The data research and information company had no specific news Friday.

  • [By Paul Ausick]

    Nielsen Holdings plc (NYSE: NLSN) dropped about 1.5% Thursday to post a new 52-week low of $40.97 after closing Wednesday at $41.59. The 52-week high is $55.94. Volume of around 5.2 million was about 70% above the daily average of around 3.2 million shares traded. The company had no specific news Thursday.

good stocks: Nektar Therapeutics(NKTR)

Advisors’ Opinion:

  • [By Sean Williams]

    Shares of Nektar Therapeutics (NASDAQ:NKTR), a biopharmaceutical company that utilizes its proprietary intellectual property via licensing deals and through collaborations in the clinical development process to help fight cancer, autoimmune diseases, and chronic pain, surged as much as 20% on Thursday after the company reported its fourth-quarter and full-year results after the closing bell on Wednesday.

  • [By Lisa Levin]

    Shares of Nektar Therapeutics (NASDAQ: NKTR) got a boost, shooting up 38 percent to $21.33 after the company reported that it has met its primary and secondary endpoints in Phase 3 Summit-07 study for chronic pain.

  • [By Ben Levisohn]

    Nektar Therapeutics (NKTR) has soared 21% to $18.80 after positive results from a pain-killer trial.

    Tiffany (TIF) has gained 1.6% to $93.90 after getting upgraded to Outperform from Market Perform at William Blair.

  • [By Todd Campbell]

    Nektar Therapeutics (NASDAQ:NKTR) is an intriguing commercial-stage biotech company that’s just reported positive late-stage trial results for its pain-busting drug NKTR-181. However, shares have jumped on the news, and the company’s market cap has swollen to more than $3 billion. Is there more running room left for its investors?